OTCM
CHFLF
Market cap3.08bUSD
Jul 09, Last price
0.35USD
1D
0.00%
IPO
-65.00%
Name
China Feihe Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
China Feihe Limited functions as an investment holding company, primarily specializing in the manufacturing and distribution of infant milk formula throughout Mainland China and the United States. The firm's product range is extensive, including various milk products such as raw milk, adult milk powders, and liquid milk, alongside a selection of health care products. Furthermore, it supplies specialized options like soybean and goat milk powders. Beyond dairy, China Feihe also engages in the retail of a wide array of nutritional supplements, including vitamins, minerals, and herbal products. Its sales strategy utilizes multiple channels, reaching customers through a network of distributors, prominent e-commerce platforms like Tmall, JD.com, and Suning.com, and directly via its corporate website and mobile applications, notably WeChat. As of December 31, 2021, the company maintained a substantial offline distribution infrastructure, serving approximately 2,000 direct customers who, in turn, managed a vast network of 110,000 retail points of sale. Established in 1962, China Feihe Limited has its corporate headquarters located in Beijing, People's Republic of China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||